Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization

Linked Content This article is linked to Bock et al and Bantel et al papers. To view these articles visit https://doi.org/10.1111/apt.13578 and https://doi.org/10.1111/apt.13826.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2017-01, Vol.45 (1), p.183-184
Hauptverfasser: He, Z.‐H., He, W.‐R., Wu, L.‐L., Zhao, C., Peng, N.‐F., Ahir, B.‐K., Lu, C.‐Y.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 184
container_issue 1
container_start_page 183
container_title Alimentary pharmacology & therapeutics
container_volume 45
creator He, Z.‐H.
He, W.‐R.
Wu, L.‐L.
Zhao, C.
Peng, N.‐F.
Ahir, B.‐K.
Lu, C.‐Y.
description Linked Content This article is linked to Bock et al and Bantel et al papers. To view these articles visit https://doi.org/10.1111/apt.13578 and https://doi.org/10.1111/apt.13826.
doi_str_mv 10.1111/apt.13820
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1845817067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1922443998</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3880-6a03c9608d6ee4e1a63ad7a97f4cadf973082fc1ddb8e3fefbe33e1b7958a24f3</originalsourceid><addsrcrecordid>eNp1kc1u1DAURi3Uig6FBS-ALHVDF2n9k0lsdlVFAWmkshjW1o1zTV2SeLAdVcOKR-AZ-yR4mJZFpXpj6_ro6Or7CHnL2Rkv5xw2-YxLJdgLsuCyWVaCyeaALJhodCUUl0fkVUq3jLGmZeIlORKt5ozXakHyCnPG-IHabQ4_MEL20_3vP1xRSBRo58MIscxpcPQGN5CDxWGYB4jUQrR-Kv804veIKfkwUXDFRnOEKUEsTw8DtTc4Bhy7MPhfxR-m1-TQwZDwzcN9TL5dfVxffq5W15--XF6sKiuVYlUDTFrdMNU3iDVyaCT0LejW1RZ6p1vJlHCW932nUDp0HUqJvGv1UoGonTwm7_feTQw_Z0zZjD7t9ocJw5wMV_VS8bakUtCTJ-htmONUtjNcC1HXUmtVqNM9ZWNIKaIzm-hLQFvDmdlVYUoV5l8VhX33YJy7Efv_5GP2BTjfA3d-wO3zJnPxdb1X_gWoZ5Yv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1922443998</pqid></control><display><type>article</type><title>Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization</title><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><creator>He, Z.‐H. ; He, W.‐R. ; Wu, L.‐L. ; Zhao, C. ; Peng, N.‐F. ; Ahir, B.‐K. ; Lu, C.‐Y.</creator><creatorcontrib>He, Z.‐H. ; He, W.‐R. ; Wu, L.‐L. ; Zhao, C. ; Peng, N.‐F. ; Ahir, B.‐K. ; Lu, C.‐Y.</creatorcontrib><description>Linked Content This article is linked to Bock et al and Bantel et al papers. To view these articles visit https://doi.org/10.1111/apt.13578 and https://doi.org/10.1111/apt.13826.</description><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/apt.13820</identifier><identifier>PMID: 27910148</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Cytokeratin ; Hepatocellular carcinoma</subject><ispartof>Alimentary pharmacology &amp; therapeutics, 2017-01, Vol.45 (1), p.183-184</ispartof><rights>2016 John Wiley &amp; Sons Ltd</rights><rights>Copyright © 2017 John Wiley &amp; Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3880-6a03c9608d6ee4e1a63ad7a97f4cadf973082fc1ddb8e3fefbe33e1b7958a24f3</citedby><cites>FETCH-LOGICAL-c3880-6a03c9608d6ee4e1a63ad7a97f4cadf973082fc1ddb8e3fefbe33e1b7958a24f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fapt.13820$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fapt.13820$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,778,782,1414,1430,27911,27912,45561,45562,46396,46820</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27910148$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>He, Z.‐H.</creatorcontrib><creatorcontrib>He, W.‐R.</creatorcontrib><creatorcontrib>Wu, L.‐L.</creatorcontrib><creatorcontrib>Zhao, C.</creatorcontrib><creatorcontrib>Peng, N.‐F.</creatorcontrib><creatorcontrib>Ahir, B.‐K.</creatorcontrib><creatorcontrib>Lu, C.‐Y.</creatorcontrib><title>Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization</title><title>Alimentary pharmacology &amp; therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>Linked Content This article is linked to Bock et al and Bantel et al papers. To view these articles visit https://doi.org/10.1111/apt.13578 and https://doi.org/10.1111/apt.13826.</description><subject>Cytokeratin</subject><subject>Hepatocellular carcinoma</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp1kc1u1DAURi3Uig6FBS-ALHVDF2n9k0lsdlVFAWmkshjW1o1zTV2SeLAdVcOKR-AZ-yR4mJZFpXpj6_ro6Or7CHnL2Rkv5xw2-YxLJdgLsuCyWVaCyeaALJhodCUUl0fkVUq3jLGmZeIlORKt5ozXakHyCnPG-IHabQ4_MEL20_3vP1xRSBRo58MIscxpcPQGN5CDxWGYB4jUQrR-Kv804veIKfkwUXDFRnOEKUEsTw8DtTc4Bhy7MPhfxR-m1-TQwZDwzcN9TL5dfVxffq5W15--XF6sKiuVYlUDTFrdMNU3iDVyaCT0LejW1RZ6p1vJlHCW932nUDp0HUqJvGv1UoGonTwm7_feTQw_Z0zZjD7t9ocJw5wMV_VS8bakUtCTJ-htmONUtjNcC1HXUmtVqNM9ZWNIKaIzm-hLQFvDmdlVYUoV5l8VhX33YJy7Efv_5GP2BTjfA3d-wO3zJnPxdb1X_gWoZ5Yv</recordid><startdate>201701</startdate><enddate>201701</enddate><creator>He, Z.‐H.</creator><creator>He, W.‐R.</creator><creator>Wu, L.‐L.</creator><creator>Zhao, C.</creator><creator>Peng, N.‐F.</creator><creator>Ahir, B.‐K.</creator><creator>Lu, C.‐Y.</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>201701</creationdate><title>Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization</title><author>He, Z.‐H. ; He, W.‐R. ; Wu, L.‐L. ; Zhao, C. ; Peng, N.‐F. ; Ahir, B.‐K. ; Lu, C.‐Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3880-6a03c9608d6ee4e1a63ad7a97f4cadf973082fc1ddb8e3fefbe33e1b7958a24f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Cytokeratin</topic><topic>Hepatocellular carcinoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>He, Z.‐H.</creatorcontrib><creatorcontrib>He, W.‐R.</creatorcontrib><creatorcontrib>Wu, L.‐L.</creatorcontrib><creatorcontrib>Zhao, C.</creatorcontrib><creatorcontrib>Peng, N.‐F.</creatorcontrib><creatorcontrib>Ahir, B.‐K.</creatorcontrib><creatorcontrib>Lu, C.‐Y.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>He, Z.‐H.</au><au>He, W.‐R.</au><au>Wu, L.‐L.</au><au>Zhao, C.</au><au>Peng, N.‐F.</au><au>Ahir, B.‐K.</au><au>Lu, C.‐Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization</atitle><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2017-01</date><risdate>2017</risdate><volume>45</volume><issue>1</issue><spage>183</spage><epage>184</epage><pages>183-184</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><abstract>Linked Content This article is linked to Bock et al and Bantel et al papers. To view these articles visit https://doi.org/10.1111/apt.13578 and https://doi.org/10.1111/apt.13826.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>27910148</pmid><doi>10.1111/apt.13820</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0269-2813
ispartof Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.183-184
issn 0269-2813
1365-2036
language eng
recordid cdi_proquest_miscellaneous_1845817067
source Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content
subjects Cytokeratin
Hepatocellular carcinoma
title Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T16%3A56%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Letter:%20cytokeratin%E2%80%9018%20as%20a%20biomarker%20of%20hepatocellular%20carcinoma%20regression%20after%20transarterial%20chemoembolization&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=He,%20Z.%E2%80%90H.&rft.date=2017-01&rft.volume=45&rft.issue=1&rft.spage=183&rft.epage=184&rft.pages=183-184&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/apt.13820&rft_dat=%3Cproquest_cross%3E1922443998%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1922443998&rft_id=info:pmid/27910148&rfr_iscdi=true